Deutsch English Français

Contact

EP3607091

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...

Extract from the Register of European Patents

EP About this file: EP3607091

EP3607091 - MODIFIED HUMAN IGM CONSTANT REGIONS FOR MODULATION OF COMPLEMENT-DEPENDENT CYTOLYSIS EFFECTOR FUNCTION [Right-click to bookmark this link]
Status	Examination is in progress Status updated on 19.01.2024 Database last updated on 24.03.2026
Former	Request for examination was made Status updated on 10.01.2020
Former	The international publication has been made Status updated on 13.10.2018
Most recent event Tooltip	24.04.2025	New entry: Renewal fee paid
Applicant(s)	For all designated states IGM Biosciences, Inc. 325 E. Middlefield Rd. Mountain View, CA 94043 / US
	[2020/10]
Former [2020/07]	For all designated states IGM Biosciences A/S Haldor Topsøes Allé 1 2800 Kgs. Lyngby / DK
Inventor(s)	01 / BALIGA, Ramesh 2237 Hopkins Avenue Redwood City California 94062 / US
	02 / NG, Dean 3966 18th Street San Francisco California 94114 / US
	[2020/07]
Representative(s)	Inspicos P/S Strandvejen 60 2900 Hellerup / DK
	[N/P]
Former [2020/07]	Inspicos P/S Kogle Allé 2 2970 Hørsholm / DK
Application number, filing date	18781914.9	06.04.2018
	[2020/07]
	WO2018US26474
Priority number, date	US201762483087P	07.04.2017 Original published format: US 201762483087 P
	[2020/07]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2018187702
	Date:	11.10.2018
	Language:	EN
	[2018/41]
	Type:	A2 Application without search report
	No.:	EP3607091
	Date:	12.02.2020
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 11.10.2018 takes the place of the publication of the European patent application.
	[2020/07]
Search report(s)	International search report - published on:	US	11.10.2018
	(Supplementary) European search report - dispatched on:	EP	18.12.2020
Classification	IPC:	C12Q1/68, A61P35/00, C07K16/00, C07K16/28	[2021/03]
	CPC:	C07K16/00 (EP,IL,KR); C07K16/2887 (EP,IL,KR,US); A61P35/00 (EP); C07K16/2809 (EP,IL,KR,US); C12Q1/68 (EP,IL); C07K2317/31 (EP,IL,KR,US); (+) C07K2317/526 (EP,IL,KR,US); C07K2317/622 (US); C07K2317/71 (EP,IL,KR,US); C07K2317/734 (EP,IL,KR,US) (-)
	Former IPC [2020/07]	C12Q1/68
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/07]
Title	German:	MODIFIZIERTE MENSCHLICHE KONSTANTE IGM-REGIONEN ZUR MODULATION DER KOMPLEMENTABHÄNGIGEN ZYTOLYSEEFFEKTORFUNKTION	[2020/07]
	English:	MODIFIED HUMAN IGM CONSTANT REGIONS FOR MODULATION OF COMPLEMENT-DEPENDENT CYTOLYSIS EFFECTOR FUNCTION	[2020/07]
	French:	RÉGIONS CONSTANTES D'IGM HUMAINE MODIFIÉE POUR LA MODULATION DE LA FONCTION EFFECTRICE CYTOLYTIQUE DÉPENDANTE DU COMPLÉMENT	[2020/07]
Entry into regional phase	07.11.2019	National basic fee paid
	07.11.2019	Search fee paid
	07.11.2019	Designation fee(s) paid
	07.11.2019	Examination fee paid
Examination procedure	07.11.2019	Examination requested [2020/07]
	16.07.2021	Amendment by applicant (claims and/or description)
	19.01.2024	Despatch of a communication from the examining division (Time limit: M06)
	17.07.2024	Reply to a communication from the examining division
Fees paid	Renewal fee
	31.03.2020	Renewal fee patent year 03
	15.04.2021	Renewal fee patent year 04
	16.03.2022	Renewal fee patent year 05
	20.04.2023	Renewal fee patent year 06
	18.04.2024	Renewal fee patent year 07
	23.04.2025	Renewal fee patent year 08
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[I] WO2015057437 (GEORGIA PACIFIC CONSUMER PROD et al.) [I] 1-15 * paragraphs [0002] , [00 6] - [0008] - [0 63] , [0 64] *
		[A] B TAYLOR ET AL: "C1q binding properties of monomer and polymer forms of mouse IgM mu- chain variants. Pro544Gly and Pro434Ala", THE JOURNAL OF IMMUNOLOGY (1950), 1 December 1994 (1994-12-01), United States, pages 5303 - 5313, XP055757445, Retrieved from the Internet [retrieved on 20201207] [A] 1-15 * example all *
		[A] J FRASER WRIGHT$ ET AL: "THE JOURNAL OF BIOLOGICAL CHEMISTRY 0 1988 by The American Society for Biochemistry and Molecular Biology C 1 Binding by Murine IgM THE EFFECT OF A PRO-TO-SER EXCHANGE A T RESIDUE 436 OF THE p-CHAIN", 15 August 1988 (1988-08-15), pages 11221 - 11226, XP055757459, Retrieved from the Internet [retrieved on 20201207] [A] 1-15 example all *
	Examination	US2015057437
		CA3055790

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.